OR WAIT null SECS
October 04, 2023
The prize was awarded jointly to Katalin Karikó and Drew Weissman for their groundbreaking discovery regarding modification of the bases in mRNA.
October 02, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
September 29, 2023
The contract is part of US Department of Health and Human Services’ ‘Project NextGen’ initiative, aimed at pushing forward new and stronger COVID-19 vaccines and therapies.
August 31, 2023
The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.
August 29, 2023
Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.
August 15, 2023
The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.
August 11, 2023
Novartis has completed its acquisition of biopharma company Chinook Therapeutics.
August 01, 2023
Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.
July 21, 2023
The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.
July 20, 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.